A Study Evaluating How Moderate Liver Impairment Affects the Absorption, Distribution, Metabolism, and Elimination of Sevabertinib After a Single Oral Dose

Clinical trial NCT07102095 · COMPLETED

Trial details

NCT number: NCT07102095
Sponsor: Bayer
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Hepatic Insufficiency Liver Diseases Pharmacokinetics Drug Metabolism

Start date: 2025-07-24
Primary completion: 2025-12-03
Enrollment: 18

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.